🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Join us today at 6pm CET at the #UnionConf Community Connect session where researchers will share the #endTB trial results with communities! MSF Science IRD Global Partners In Health Unitaid

.IRD Global MSF International Partners In Health , and funder Unitaid would like thank all those who attended the endTB clinical trial results presentations at the #UnionConf this week! Safe travels home and stay tuned!

Premiering now: MASSIVE tuberculosis news. youtube.com/watch?v=T-Xdob…

Joining hands for #WTBDay 2024, the endTB trial community met at IRD’s Community Dissemination Event. They celebrated their contribution in advancing knowledge for the treatment of MDR-TB. Partners In Health MSF International Unitaid #irdglobal #tuberculosis 1/2.

On this #WorldTBDay24 , join #endTB in celebrating last year’s achievements in the fight against multidrug-resistant #tuberculosis. Check out our latest news and results: endtb.org/news-stories and endtb.org/endtb-clinical… MSF France IRD Global Partners In Health Unitaid UC San Francisco

Save the date! 🚀 The MSF Scientific Days Southern Africa 2024 are starting tomorrow, Wed. April 17. We thank Dr. Kunda Mikanda, Principal Investigator of the endTB Clinical Trials site in Lesotho, who will present the results of the trial on improving the treatment of MDR-TB.

The endTB trial results increase patient-centred treatment options for RR/MDR-TB with three shortened, all-oral, noninferior regimens to a current well-performing standard of care. #MSFSciDaysSA2024 More details 👉msfsa.me/3vZYMh9

🌟 Exciting news! Today at #ESCMIDGlobal2024, Dr. Lorenzo Guglielmetti, Director of the #endTB project, will be presenting a groundbreaking comparison of efficacy and safety between experimental regimens for MDR-TB from the endTB clinical trial (Hall H, 13:30-15:30).

🌟Join us on May 23, for #EpicentreScientificDay! Maelenn Gouillou, Biostatistician of the endTB project, will present findings on drug-resistant tuberculosis subgroups from the #endTB clinical trial. Don't miss it at 2:15pm at Salons de l'Aveyron in Paris. More info here👇🏾

The endTB consortium partners are happy to report that the last visit for the last study participant in the endTB-Q trial was completed on 22 July! Read more: bit.ly/3Sm1oy0 MSF Science Partners In Health IRD Global Unitaid

📢 Breaking news: in a rapid communication, the WHO recommended 3 new, shorter, more tolerable regimens for MDR/RR-TB, which were studied in the endTB clinical trial! More details 👉bit.ly/4fUAsPS MSF Science Partners In Health IRD Global Unitaid

📢The results of the endTB-Q clinical trial, which assesses the safety and efficacy of a new and shorter regimen for the treatment of pre-XDR-TB, will be presented for the first time at the #UnionConf in Bali on Nov 13.👉bit.ly/endTB-Q MSF Science Partners In Health IRD Global Unitaid

Reminder: the presentation of the endTB-Q clinical trial results is happening tomorrow at the #UnionConf in Bali! More here👉bit.ly/endTB-Q. And stay tuned for details about the results of this groundbreaking trial! MSF Science Partners In Health IRD Global Unitaid